PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Type 2 Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Age 18+ with Type 2 Diabetes

A 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with Type 2 Diabetes.

2013-03-02
BIRMINGHAM, AL, March 02, 2013 (Press-News.org) *Achieve Clinical Research conducts Clinical Trials in Birmingham, Alabama. For more information about getting started with a Diabetes Clinical Trial, please visit our website or contact us directly at (205) 380-6434

BACKGROUND AND RATIONALE

Type 2 diabetes mellitus (T2DM) is a multi-organ disease characterized by defective insulin action in the liver, adipose tissue and skeletal muscle and a relative impairment of insulin secretion capacity. At diagnosis, subjects with T2DM have only 50% of their beta-cell function remaining and with progressing disease patients become profoundly insulin deficient requiring insulin therapy to restore glycaemic control.

In addition, a blunted secretion and/or action of incretin hormones glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) from the gastro-intestinal tract in response to a meal are also characteristic of T2DM. GLP-1 is an important postprandial hormone secreted from the L-cells in the intestine with a stimulating effect on insulin secretion and an inhibitory role on glucagon secretion from the endocrine pancreas in a glucose-dependent manner.

You can also read more diabetes news at our blog.

PRIMARY OBJECTIVE

To confirm superiority of insulin degludec/liraglutide versus unchanged GLP-1 receptor agonist therapy in controlling glycaemia in insulin naive subjects with T2DM inadequately controlled on GLP-1 receptor agonist therapy in combination with metformin±pioglitazone±sulphonylurea.

SECONDARY OBJECTIVE

To compare general efficacy and safety of insulin degludec/liraglutide versus unchanged GLP-1 receptor agonist therapy in insulin naive subjects with T2DM inadequately controlled with GLP-1 receptor agonist therapy in combination with metformin±pioglitazone±sulphonylurea after 26 weeks of treatment.

INCLUSION CRITERIA

1. Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial

2. Type 2 diabetes mellitus

3. Male or female over 18 years of age

4. HbAlc 7.0-9.0% (53-75 mmol/mol) (both inclusive)

5. Treatment with daily GLP-1 receptor agonist at maximum dose according to local label (i.e. 1.8 mg OD Victoza (liraglutide) or 10 microgram BID Byetta (exenatide)) or documented maximum tolerated dose (i.e. 1.2 mg OD Victoza (liraglutide) or 5 microgram BID Byetta (exenatide)) in combination with a stable daily dose of metformin (more than 1500 mg or documented maximum tolerated dose) ± stable daily dose of pioglitazone (more than30 mg) ±stable daily dose of sulphonylurea (more than half of the max approved dose according to local label) more than 90 days prior to screening visit (Visit 1)

6. BMI less than 40 kg/m^

7. Able and willing to adhere to the protocol including performing self measured plasma glucose profiles, to keep a trial diary and to use pre-filled pen device

For information about how to participate in this type 2 diabetes clinical trial, visit Achieve Clinical Research or contact us directly at (205) 380-6434


ELSE PRESS RELEASES FROM THIS DATE:

Grauer School 6th Grade Student Exemplifies Impact of Small Schools Movement

2013-03-02
Alexandra Parker is a 6th grade student that represents the qualities inspired by the nationally growing small-schools educational model. Alexandra's outstanding accomplishments epitomize the potential that the Grauer School in Encinitas is renowned for cultivating and that results in an increasing record number of unsolicited merit scholarships offered to Grauer graduates annually. Encompassing the core of the small schools movement (personalized, all-inclusive, self-goverened schools serving no more than 350 students), the successful technique has motivated Alexandra ...

Domusstudio Architecture Completes Greenhouse-Inspired Fire Station #2 in Encinitas

2013-03-02
Local flower fields and greenhouses inspired the design for Encinitas Fire Station #2, which was unveiled to the public on Feb. 22 and has been serving the community since early January. Located at 618 Birmingham Dr. in Encinitas, the facility designed by San Diego firm domusstudio architecture replaced the outdated Fire Station #2 building. The new fire station is highly visible along Interstate 5 in Encinitas, and is located just east of the previous station site. According to domusstudio architect Wayne Holtan, the single-story, 6,330 square-foot building—with ...

Julienne Johnson Unveils New Exhibition at LA Artcore Brewery Annex March 3rd - 30th, 2013

2013-03-02
Julienne Johnson's latest body of work continues her exploration of communication and connectivity through her mixed media paintings on exhibit at LA Artcore - Brewery Annex, March 3 - 30, 2013. The opening reception and conversation with the artist will commence on Sunday, March 3rd. Johnson has coordinated a closing reception and poetry reading: SPOKEn WORD & PAINT, featuring acclaimed writers, Peter Frank (international art critic, curator, poet) and Jack Grapes (award winning poet, playwright, actor, teacher). The poetry reading will coincide with the closing of ...

DCS Industries, LLC Announces the CAL Double Bolt Lock to Product Line

2013-03-02
DCS Industries, LLC in Phoenix, AZ is proud to announce the addition of CAL Double Bolt Locks to their selection of home and pool safety products. According to the manufacturer, "The CAL Double-Bolt Lock works by securing the door to the frame at two security points and preventing any movement of the door. With its double locking action the CAL Double-Bolt Lock makes it virtually impossible to remove the door by lifting it off its track." DCS Industries is currently offering a discounted price on purchase and installation of the CAL Double-Bolt Lock. Normally ...

Journey Bar Shakes Up Their Savory Bars

2013-03-02
Savory bars offer the flavor variety and lower-sugar options consumers are demanding in their nutrition bars Journey Bar shook up the bar aisle in 2012 when it broke away from the typical sweet nutrition bar flavors and launched its line savory flavored bars. Now, Journey Bar is excited to announce significant changes to their product line, including: new flavors, a new softer and chewier texture, and more protein! Additionally, Journey Bars are now all vegan and gluten-free. Journey Bar is set to debut their new and improved line at Natural Products Expo West in Anaheim, ...

Apricot Lane Expansion Planned for Charlotte

2013-03-02
Apricot Lane, a popular national boutique featuring celebrity-inspired affordable fashions for the everyday woman, is expanding its footprint in the Southeast with three stores planned for the Charlotte market. The chain, which operates under the franchise company Country Visions and has its corporate office in California, previously had one store in the area, located in Huntersville's Birkdale Village. That store closed in early February and was revamped under new ownership. It will officially reopen by this Friday, March 1. All visitors to the new Huntersville store ...

greeNEWit Co-Founder and Social Entrepreneur Speaks at University of Maryland's Fifth Annual Social Enterprise Symposium

2013-03-02
Social entrepreneurs are individuals with innovative solutions to societyâEUR s most pressing social problems. What does it take to be one, and what are the challenges? Students from the Robert H. Smith School of Business at the University of Maryland will have the opportunity to ask greeNEWit Co-Founder Josh Notes at the Creating Value Social Enterprise Symposium on March 1, 2013 at the Stamp Student Union. Notes is one of five social entrepreneurs who are tackling issues ranging from education to the environment. He will be leading the "Storytellers: From the ...

TharpeRobbins Receives Safe Harbor Privacy Compliance from U.S. Department of Commerce

2013-03-02
The TharpeRobbins Company, a global leader in managed employee rewards and recognition, recently completed the U.S. Department of Commerce's Safe Harbor privacy protection certification process. Safe Harbor certification is a program developed by the U.S. Department of Commerce in consultation with the European Commission to assist U.S. companies in complying with the European Union's Directive on Data Protection. Requiring adherence to seven key principles relating to data access, transfer and security, certification provides the public with an assurance that participating ...

Melanic Tees Debuts New Tee's for Spring Tribal Coolection 2013

2013-03-02
Melanic Tees debuts New Tee's for Spring Tribal Coolection 2013 Los Angeles, CALI Native Annae Padilla aka Api creator of Melanic Tees Coolection will be debuting her New Tees for her Coolection of Cool, Feminine Tees featuring fluency, tribal designs and Indigenous patterns. "I was inspired to do a Tee line specifically for Women&girls of color because I feel there is a definite absence of Models Keen to Native, Indigenous Melaninated People. I am very conscious of the Fashion World that uses "tribal or native" designs for seasonal or recreational ...

New Music Reality Show Will Showcase Unsigned Acts and "Hit" Song Remakes.

2013-03-02
Cover Me is a "Behind the Music" series based in Austin, Texas. It will feature a group of musicians and singers collectively known as "The Cover Kings". The show is currently running a campaign on Kickstarter.com. This musical biography will explore some of the the greatest hit songs of our time and the artists that made them famous. Cover Me will examine some 90 iconic artists ranging from ABBA to ZZ Top, relate the story of the song and the artist - and then create a modern interpretation of the material. Combining new music technology and Austin's ...

LAST 30 PRESS RELEASES:

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

Fat may play an important role in brain metabolism

New study finds no lasting impact of pandemic pet ownership on human well-being

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Gut microbes could protect us from toxic ‘forever chemicals’

Novel modelling links sea ice loss to Antarctic ice shelf calving events

Scientists can tell how fast you're aging from a single brain scan

U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050

Public take the lead in discovery of new exploding star

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing

New book Terraglossia reclaims language, Country and culture

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

[Press-News.org] Type 2 Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Age 18+ with Type 2 Diabetes
A 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with Type 2 Diabetes.